GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxil Bio Ltd (TSXV:VXL) » Definitions » Price-to-Free-Cash-Flow

Vaxil Bio (TSXV:VXL) Price-to-Free-Cash-Flow : N/A (As of May. 20, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Vaxil Bio Price-to-Free-Cash-Flow?

As of today (2024-05-20), Vaxil Bio's share price is C$0.01. Vaxil Bio's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.00. Hence, Vaxil Bio's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Vaxil Bio's Price-to-Free-Cash-Flow or its related term are showing as below:

TSXV:VXL's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 32.93
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Vaxil Bio's Free Cash Flow per Share for the three months ended in Dec. 2023 was C$-0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was C$-0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 30.70% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 16.90% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 29.70% per year.

During the past 13 years, Vaxil Bio's highest 3-Year average Free Cash Flow per Share Growth Rate was 64.20% per year. The lowest was 10.10% per year. And the median was 39.50% per year.


Vaxil Bio Price-to-Free-Cash-Flow Historical Data

The historical data trend for Vaxil Bio's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxil Bio Price-to-Free-Cash-Flow Chart

Vaxil Bio Annual Data
Trend May14 May15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Vaxil Bio Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Vaxil Bio's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Vaxil Bio's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaxil Bio's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vaxil Bio's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Vaxil Bio's Price-to-Free-Cash-Flow falls into.



Vaxil Bio Price-to-Free-Cash-Flow Calculation

Vaxil Bio's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.01/-0.004
=N/A

Vaxil Bio's Share Price of today is C$0.01.
Vaxil Bio's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Vaxil Bio  (TSXV:VXL) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Vaxil Bio Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Vaxil Bio's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Vaxil Bio (TSXV:VXL) Business Description

Traded in Other Exchanges
Address
C/O Kira Lynn, Bennet Jones LLP, 3400 One First Canadian Place, Toronto, ON, CAN, M5X 1A4
Vaxil Bio Ltd is an Israeli immunotherapy biotech company focused on a novel drug discovery and development platform based on Signal Peptides which the company deploys to fight infectious diseases and cancer.

Vaxil Bio (TSXV:VXL) Headlines

No Headlines